BiotechTube
Home/Fulcrum Therapeutics/Esther Rajavelu
ER

Esther Rajavelu

Chief Financial Officer

Fulcrum Therapeutics

Roles

Chief Financial OfficeratFulcrum Therapeutics
President and Chief Executive OfficeratSpero Therapeutics

Therapeutic Areas

Rare DiseasesMuscular DystrophyGenetic DisordersHematology

Fulcrum Therapeutics Pipeline

DrugIndicationPhase
Losmapimod (FHD-286)Facioscapulohumeral Muscular Dystrophy (FSHD)Phase 3
FTX-6058Sickle Cell DiseasePhase 1b
FHD-909Chronic Obstructive Pulmonary Disease (COPD)Preclinical

Leadership Team at Fulcrum Therapeutics

BE
Bryan E. Stuart
President and Chief Executive Officer
RJ
Robert J. Gould, Ph.D.
Chairman of the Board
CM
Chris Moxham, Ph.D.
Chief Scientific Officer
JD
Judith Dunn, Ph.D.
President of Research and Development
DL
Daniel L. Karp, M.D.
Chief Medical Officer
OH
Owen Hughes
Chief Business Officer
AB
Alexis Borisy
Director
KH
Kate Haviland
Director
CS
Catherine Stehman-Breen, M.D.
Director
SB
Stephen Brannan, M.D.
Director
View full Fulcrum Therapeutics profile